Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
These findings point to new directions for treatment, offering hope to those affected by eating disorders. The article also discusses the need for further investigation of GLP-1 medication misuse as an eating disorder symptom and describes cognitive-behavioral therapy as a first-line treatment for bulimia and related disorders
A.BevanS
Following Matrigel polymerization for 10 min at 37 C, advanced DMEM/F12 was supplemented with penicillin/streptomycin, 2 mM GlutaMAX, 10 mM HEPES, 1 B27, 1 N2 (Life Technologies), 1mM N-acetylcysteine (Sigma), and 10 nM gastrin I (Biogems)
Learn more about peptide storage after reconstitution for related guidance
Gradual potency loss from temperature exposure does not change the solution appearance
(PubMed) Lagowska-Lenard M, Stelmasiak Z, Bartosik-Psujek H
US$ 28.92
US$ 20.34
US$ 26.39
US$ 25.99
